The genetic make-up of an individual contributes to the susceptibility and response to viral
infection. Although environmental, clinical and social factors have a role in the chance of …

It has recently been shown that repeated large-volume paracentesis associated with
intravenous albumin infusion is a rapid, effective, and safe therapy of ascites in cirrhosis. To …

Background Patients with reflux esophagitis have a high rate of relapse within one year after
therapy is discontinued. Methods We enrolled 175 adults with endoscopy-confirmed reflux …

To identify prognostic factors in cirrhotic patients admitted to the hospital for the treatment of
an episode of ascites, a survival analysis was performed in a series of 139 patients …

The aim of this retrospective study was to determine the predictive value of alanine
aminotransferase (ALT) levels for histologic findings in patients with chronic hepatitis C virus (HCV) …

Ascites is a complication of chronic liver disease that is associated with decreased survival.
The purpose of the present study was to identify some prognostic factors easily obtainable by …

From 1983 through 1997, our center diagnosed 130 cases of benign neoplasms: 27 with
focal nodular hyperplasia (FNH), 25 with hepatic adenoma, 71 with cavernous hemangioma, …

Repeated large-volume paracentesis (4–6 L/day) is an effective and safe therapy of ascites
in patients with cirrhosis provided albumin is infused intravenously. To investigate whether …

Objective Satavaptan, a vasopressin V2 receptor antagonist, has been shown to improve
the control of ascites in cirrhosis in short-term phase II studies. The aim of this study was to …

Objectives The ALIGN study ( NCT01061723 ) evaluated the efficacy and safety of sarilumab,
the first fully human monoclonal antibody against interleukin-6 receptor-α (IL-6Rα), in …